References
- Li Q, Guan X, Wu P, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med. 2020;382(13):1199–1207.
- CSSE J. https://coronavirus.jhu.edu/map.html. Published 2020. Accessed August 17, 2020.
- WHO. https://www.who.int/emergencies/diseases/novel-coronavirus-2019. Published 2020
- Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506. doi:https://doi.org/10.1016/S0140-6736(20)30183-5.
- Leisman DE, Deutschman CS, Facing LM. COVID-19 in the ICU: vascular dysfunction, thrombosis, and dysregulated inflammation. Intensive Care Med. 2020;46(6):1105–1108. doi:https://doi.org/10.1007/s00134-020-06059-6.
- Li Y, Xia L. Coronavirus disease 2019 (COVID-19): role of chest CT in diagnosis and management. AJR Am J Roentgenol. 2020;214(6):1280–1286. doi:https://doi.org/10.2214/AJR.20.22954.
- Caruso D, Zerunian M, Polici M, et al. Chest CT features of COVID-19 in Rome, Italy. Radiology. 2020;296(2):E79–E85. doi:https://doi.org/10.1148/radiol.2020201237.
- Spagnolo P, Cozzi A, Foà RA, et al. CT-derived pulmonary vascular metrics and clinical outcome in COVID-19 patients. Quant Imaging Med Surg. 2020;10(6):1325–1333. doi:https://doi.org/10.21037/qims-20-546.
- Ikram MK, Ong YT, Cheung CY, Wong TY. Retinal vascular caliber measurements: clinical significance, current knowledge and future perspectives. Ophthalmologica. 2012;229:125–136. doi:https://doi.org/10.1159/000342158.
- Sun C, Wang JJ, Mackey DA, Wong TY. Retinal vascular caliber: systemic, environmental, and genetic associations. Surv Ophthalmol. 2009;54:74–95. doi:https://doi.org/10.1016/j.survophthal.2008.10.003.
- Arichika S, Uji A, Ooto S, et al. Comparison of retinal vessel measurements using adaptive optics scanning laser ophthalmoscopy and optical coherence tomography. Jpn J Ophthalmol. 2016;60:166–171. doi:https://doi.org/10.1007/s10384-016-0435-3.
- Muraoka Y, Tsujikawa A, Kumagai K, et al. Age- and hypertension-dependent changes in retinal vessel diameter and wall thickness: an optical coherence tomography study. Am J Ophthalmol. 2013;156(4):706–714. doi:https://doi.org/10.1016/j.ajo.2013.05.021.
- Ouyang Y, Shao Q, Scharf D, et al. Retinal vessel diameter measurements by spectral domain optical coherence tomography. Graefes Arch Clin Exp Ophthalmol. 2015;253(4):499–509. doi:https://doi.org/10.1007/s00417-014-2715-2.
- Merad M, Martin JC. Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages. Nat Rev Immunol. 2020;20(6):355–362. doi:https://doi.org/10.1038/s41577-020-0331-4.
- Zhao W, Zhong Z, Xie X, et al. Relation between chest CT findings and clinical conditions of coronavirus disease (COVID-19) pneumonia: a multicenter study. AJR Am J Roentgenol. 2020;214(5):1072–1077. doi:https://doi.org/10.2214/AJR.20.22976.
- Wu P, Duan F, Luo C, et al. Characteristics of ocular findings of patients with coronavirus disease 2019 (COVID-19) in Hubei Province, China. JAMA Ophthalmol. 2020;138(5):575–578. doi:https://doi.org/10.1001/jamaophthalmol.2020.1291.
- Casagrande M, Fitzek A, Püschel K, et al. Detection of SARS-CoV-2 in human retinal biopsies of deceased COVID-19 patients. Ocul Immunol Inflamm. 2020;1–5.
- Seah I, Agrawal R. Can the coronavirus disease 2019 (COVID-19) affect the eyes? A review of coronaviruses and ocular implications in humans and animals. Ocul Immunol Inflamm. 2020;28(3):391–395. doi:https://doi.org/10.1080/09273948.2020.1738501.
- Zhang H, Penninger JM, Li Y, Zhong N, Slutsky AS. Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target. Intensive Care Med. 2020;46:586–590. doi:https://doi.org/10.1007/s00134-020-05985-9.
- Verma A, Shan Z, Lei B, et al. ACE2 and Ang-(1–7) confer protection against development of diabetic retinopathy. Mol Ther. 2012;20:28–36. doi:https://doi.org/10.1038/mt.2011.155.
- Duan Y, Beli E, Li Calzi S, et al. Loss of angiotensin-converting enzyme 2 exacerbates diabetic retinopathy by promoting bone marrow dysfunction. Stem Cells. 2018;36:1430–1440. doi:https://doi.org/10.1002/stem.2848.
- Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020;18:844–847. doi:https://doi.org/10.1111/jth.14768.
- Varga Z, Flammer AJ, Steiger P, et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395:1417–1418. doi:https://doi.org/10.1016/S0140-6736(20)30937-5.
- Jung F, Krüger-Genge A, Franke R, Hufert F, Küpper JHCOVID-19. and the endothelium. Clin Hemorheol Microcirc. 2020;75(1):7–11.
- Wong TY, Klein R, Sharrett AR, et al. Retinal arteriolar narrowing and risk of coronary heart disease in men and women: the Atherosclerosis Risk in Communities Study. JAMA. 2002;287:1153–1159. doi:https://doi.org/10.1001/jama.287.9.1153.
- Wong TY, Klein R, Sharrett AR, et al. Retinal arteriolar narrowing and risk of diabetes mellitus in middle-aged persons. JAMA. 2002;287:2528–2533. doi:https://doi.org/10.1001/jama.287.19.2528.
- Wong TY, Shankar A, Klein R, Klein BE, Hubbard LD. Prospective cohort study of retinal vessel diameters and risk of hypertension. BMJ. 2004;329:79–82. doi:https://doi.org/10.1136/bmj.38124.682523.55.
- Wong TY, Klein R, Couper DJ, et al. Retinal microvascular abnormalities and incident stroke: the atherosclerosis risk in communities study. Lancet. 2001;358:1134–1140. doi:https://doi.org/10.1016/S0140-6736(01)06253-5.
- Nguyen TT, Islam FMA, Farouque HMO, et al. Retinal vascular caliber and brachial flow-mediated dilation: the multi-ethnic study of atherosclerosis. Stroke. 2010;41:1343–1348. doi:https://doi.org/10.1161/STROKEAHA.110.581017.
- Klein R, Klein BEK, Knudtson MD, et al. Are inflammatory factors related to retinal vessel caliber? The Beaver dam eye study. Arch Ophthalmol. 2006;124:87–94. doi:https://doi.org/10.1001/archopht.124.1.87.
- Yang AP, Liu JP, Tao WQ, et al. The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients. Int Immunopharmacol. 2020;84:106504. doi:https://doi.org/10.1016/j.intimp.2020.106504.
- Consigli A, Papanastasiou A, Roquelaure D, et al. Changes in retinal vascular caliber after intravitreal aflibercept treatment for diabetic macular oedema. Klin Monbl Augenheilkd. 2019;236:1318–1324.
- Lundberg K, Kawasaki R, Sjølie AK, Wong TY, Grauslund J. Localized changes in retinal vessel caliber after focal/grid laser treatment in patients with diabetic macular edema: a measure of treatment response? Retina. 2013;33(10):2089–2095. doi:https://doi.org/10.1097/IAE.0b013e3182891dda.